aztreonam has been researched along with Acute Lymphoid Leukemia in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam was discontinued in both patients." | 1.28 | Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients. ( Bianco, JA; McDonald, BJ; Singer, JW, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McDonald, BJ | 1 |
| Singer, JW | 1 |
| Bianco, JA | 1 |
1 other study available for aztreonam and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients.
Topics: Adult; Aztreonam; Bacterial Infections; Bone Marrow Transplantation; Graft vs Host Disease; Humans; | 1992 |